Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®
Clinical trial NCT05898984 · COMPLETED
Trial details
- NCT number
- NCT05898984
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2023-07-14
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.